# Symptoms and phases of mucopolysaccharidosis
Mucopolysaccharidosis (MPS) varies widely depending on the type. This is because there are more than ten different types, each caused by the lack of a different enzyme. Some forms begin with obvious symptoms in the first months of life, others only around the second or third year of life. The rate at which symptoms get worse varies greatly by type and by person.
This overview describes the most common types and their typical course. Because MPS is a very diverse group of diseases, the phases cannot always be divided tightly into closed boxes — many symptoms start gradually and overlap.
Early phase (first symptoms)
In this phase, the first signs begin to stand out, although they are sometimes subtle and easy to overlook.
**Most common symptoms: **
- **Growth and development: ** Some forms are associated with a slowdown in body growth, or, on the contrary, a significantly larger size of certain parts (especially the head). In some types, it is noticeable that the child is lagging behind in terms of motor development (foundations, walking), or that movements are becoming slower or stiffer.
- **Face and skull: ** Facial features may gradually change: nose widens, lips fuller, jaw larger. The head may grow larger than normal (macrocephaly). Some children get a noticeable protruding chin. These changes are sometimes subtle at the beginning.
- **Infections: ** Many children with MPS get respiratory and ear infections more often than their peers. This is because the connective tissue in the nose, throat and ears thickens and becomes clogged.
- **Abdomen: ** An enlargement of the liver and/or spleen (hepatosplenomegaly) can be felt as a fuller belly.
- **Eyes: ** Clouding of the eye lens (cornea) may occur, causing the vision to gradually become less sharp. This is not always immediately visible.
- **Movement: ** Stiffness in joints, especially in the hands and feet, may be noticeable when the child tries to crawl or grasp.
- **Sound: ** Some children develop a raw, less clear voice.
**What this means in daily life:**
A child in this phase often still feels quite alone, but parents notice that things are not quite the same as with other children. Regular hospital visits and examinations are becoming normal. The diagnosis is often made in this phase, especially if newborn screening is used or if the child shows several symptoms at the same time.
**Figures about this phase: **
Most types of MPS are discovered around the first to third year of life (some within the first months), although this depends a lot on the type and how alert healthcare providers are. The rate of progression varies enormously — some children deteriorate rapidly, others much slower.
Progressive phase (increase in symptoms)
As the months and years go by, symptoms gradually get worse. In this phase, the disease begins to show itself more clearly in everyday life.
**Most common symptoms: **
- **Growth: ** Growth slowdown becomes more evident. Many children with MPS grow shorter than their peers, although this varies greatly by type. In Morquio syndrome (type IV), growth restriction can be very pronounced.
- **Face and appearance: ** The facial changes are pronounced. The nose is getting wider, the face is swelling, the appearance is becoming more and more characteristic of MPS. This can affect how children feel and how they are seen by others.
- **Skeletal System and Movement: **
- Joints are getting stiffer. Hands can take a bent position, feet can grow crooked.
- The spinal cord can be pressured by thickened structures around the spine, causing rigidity, pain and, in severe cases, loss of sensation in the arms or legs.
- Loss of height occurs. Children not only grow shorter, but the spine can also develop curvature (scoliosis, kyphosis).
- Hands become increasingly difficult to use; grip and fine motor skills decline.
- **Heart and circulation:** In many types, heart valve problems develop, especially the mitral valve. This can lead to exertion-related fatigue and shortness of breath. High blood pressure can occur.
- **Ears and hearing:** Hearing support can worsen, both from deformed ear bones and from regular infections and fluid buildup. This impairs speech and learning.
- **Eyes:** Corneal cloudiness (keratitis) can progress; some types lead to retinal degeneration causing progressive vision loss.
- **Breathing:** The airways remain sensitive; children have frequent infections (bronchitis, pneumonia). In some types, sleep apnea episodes can occur.
- **Speech and language:** Due to hearing difficulties, jaw and tongue stiffness, and in some types cognitive delays, speech becomes less clear. Communication becomes increasingly challenging.
- **Cognition and behavior:** In certain types (especially MPS IIIA, IIIB, IIIC — Sanfilippo syndrome), a decline in learning, memory, and behavior becomes increasingly noticeable. This can begin after a child was initially developing normally.
- **Abdomen:** Liver and spleen can enlarge further. Hernias can occur due to weakened abdominal muscles.
**What this means in daily life:**
A child in this phase requires regular medical treatment. Physiotherapy, speech therapy, and other support become important. Attending school becomes difficult; many children transition to special education. Eating independently, washing, and using the toilet can become increasingly difficult. Family and school adapt to slower paces and growing care needs. Regular checks of heart function, spine, and pressure points become standard.
**Figures about this phase: **
In more slowly progressive types (e.g., MPS I, VI, VII), these symptoms can unfold over years — sometimes 5 to 10 years or longer. In faster progressive forms like MPS IIIA (Sanfilippo type A), this phase can be much shorter, sometimes just a few years.
For MPS IIIA for example: children often begin showing symptoms around age two, and by age six to ten, severe decline and behavioral changes can become dominant (source: various clinical case reports, 2024–2026).
Because this varies so widely, population-wide median figures are difficult to provide. Individual prognoses depend on many factors: the exact type, mutations, age at diagnosis, whether and what treatment is started, and other health conditions.
Late phase (systemic complications)
Without treatment (or if treatment has insufficient effect), serious complications arise affecting much of the body.
**Most common symptoms: **
- **Heart:** Heart valve disease can progressively worsen, causing heart failure. This leads to fatigue, fluid buildup, shortness of breath, especially with exertion.
- **Spinal cord and nervous system:**
- Spinal cord compression can cause paralysis of the legs and arms, as well as radiating pain and loss of sensation.
- In certain types (especially the neuropathic forms of type III — Sanfilippo), progressive loss of cognitive functions occurs, followed by motor decline. The child may eventually be unable to sit upright, walk, or communicate independently.
- Seizures and muscle spasms can occur.
- **Lungs:** Chronic airway symptoms, sleep apnea, and infections become harder to manage. Breathing problems can worsen at night.
- **Kidneys and urinary tract:** Kidney function can gradually decline.
- **Nutrition:** Due to jaw stiffness, swallowing difficulties, and reduced ability to take in food, malnutrition can develop. Artificial feeding via tube may become necessary.
- **Infections:** The immune system is not directly affected, but frequent infections become increasingly difficult to fight off.
- **Blindness and deafness:** In certain types, both sight and hearing can be completely lost.
**What this means in daily life:**
The child is entirely dependent on care. Home or hospital care becomes necessary. Medical support (possibly ventilation, tube feeding, medication) becomes part of daily life. Communication happens through very limited channels. Pain management and comfort become central to care.
**Figures about this phase: **
Without treatment: for MPS IIIA, median life expectancy is approximately 11–17 years (different studies point to the same order of magnitude, 2020–2025). For other severe neuronal types, comparable life expectancy. For more slowly progressive types (MPS I, VI, VII), patients can survive into adulthood and sometimes longer — sometimes 20–30 years or more.
These figures are averages across large groups. Individual trajectories vary greatly. Early diagnosis and treatment can change these numbers further. Medical complications (heart failure, infections, spinal cord compression) are often directly determining for timing.
Effect of treatment on progression
In recent years, enzyme replacement therapies (ERT) and other treatments have become available for various MPS types. These can slow progression or stabilize certain aspects, but usually do not provide a complete cure.
- **Which types:** Enzyme replacement therapy is available for, among others, MPS I, II (Hunter), IV (Morquio), VI and VII. For more severe neuronal types (MPS III — Sanfilippo), therapies are in development and research.
- **Effect:** Patients who start ERT early in the disease often show less pronounced progression of skeletal symptoms and organ enlargement, and can maintain more mobility and quality of life. The effect on cognitive decline (in type III) is even more limited.
- **Stem cell transplantation:** In certain cases (especially MPS I), stem cell transplantation or bone marrow transplantation is considered, particularly in young children. This can provide significant stabilization, especially for non-neurological symptoms, but also carries its own risks.
The timing of treatment initiation, the type of treatment, and how well the patient responds to it, strongly determines how the disease unfolds further.
When to contact the healthcare provider
Parents and caregivers watch carefully for certain signals:
- Sudden worsening of movement, sensation or strength in legs or arms (may indicate spinal cord compression).
- Severe shortness of breath, especially at night or with activity (heart failure or lung problems).
- Difficulties with swallowing, weight loss, or signs of malnutrition.
- Severe pain complaints that are not well relieved.
- Sudden behavioral changes or mental confusion.
- High fever or signs of serious infection.
- Sudden change in consciousness or responsiveness.
Regular contact with the treatment team remains important, even between scheduled check-ups.
---
_This information never replaces the judgment of a